Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B
By Swati Sharan & Michelle Liu
Pharma Deals Review: Vol 2021 Issue 4 (Table of Contents)
Published: 16 Apr-2021
DOI: 10.3833/pdr.v2021.i4.2607 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Eli Lilly has agreed to acquire Prevail Therapeutics, a gene therapy company focused on the development of disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS